The interrogation of this database revealed that in seminoma tumors, where PTTG1 is more localized in the nucleus than in the nonseminoma subtype, a significantly lower E-CAD expression is observed compared to the observations of nonseminomas. Here, PTTG1 is linked to seminoma.